Company profile for BOOST Pharma

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

BOOST Pharma is a clinical-stage biopharmaceutical company developing a first-in-class cell therapy for Osteogenesis Imperfecta (OI), a rare inherited bone disorder. Founded on research from Karolinska Institutet in Stockholm, the company is advancing BT-101, an allogeneic mesenchymal stem cell therapy designed to address the underlying cause of OI and reduce fractures in children. BT-101 has demonstrated strong bone-forming p...
BOOST Pharma is a clinical-stage biopharmaceutical company developing a first-in-class cell therapy for Osteogenesis Imperfecta (OI), a rare inherited bone disorder. Founded on research from Karolinska Institutet in Stockholm, the company is advancing BT-101, an allogeneic mesenchymal stem cell therapy designed to address the underlying cause of OI and reduce fractures in children. BT-101 has demonstrated strong bone-forming potential, clinical proof-of-concept, and favorable safety, with positive Phase I/II results and an FDA-accepted development plan toward Phase III studies.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
Denmark
Address
Address
Ole Maaløes Vej 3 2200 Copenhagen N
Telephone
Telephone
Linkedin
Linkedin
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

AMWC Asia-TDAC

AMWC Asia-TDAC

Not Confirmed

envelop Contact Supplier

AMWC Asia-TDAC

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.pharmiweb.com/press-release/2026-03-19/boost-pharma-appoints-leading-biopharma-leader-elaine-jones-as-chair

PHARMIWEB
19 Mar 2026

https://www.globenewswire.com/news-release/2026/02/10/3235289/0/en/Hans-Schambye-Appointed-as-Chief-Executive-Officer-of-BOOST-Pharma.html

GLOBENEWSWIRE
10 Feb 2026

https://www.pharmabiz.com/NewsDetails.aspx?aid=184081&sid=1

PHARMABIZ
07 Feb 2026

https://www.pharmiweb.com/press-release/2026-01-07/roslinct-and-boost-pharma-announce-strategic-manufacturing-agreement-to-advance-cell-therapy-for-inf

PHARMIWEB
07 Jan 2026

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty